List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 22 studies with search of: "Condyloma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients
Conditions: HIV Infections;   Condyloma Acuminata
Intervention: Drug: Cidofovir
2 Active, not recruiting Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts
Conditions: External Genital Warts;   Perianal Warts;   Condylomata Acuminata
Interventions: Drug: imiquimod cream A;   Drug: imiquimod cream B;   Drug: placebo
3 Completed Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts
Condition: Condylomata Acuminata
Intervention: Drug: Polyphenon E Ointment 10%, Polyphenon E Ointment 15%
4 Terminated Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study
Conditions: Cervical Cancer;   Condylomata Acuminata
Intervention: Biological: V502
5 Active, not recruiting An Investigational Study of Gardasil (V501) in Reducing the Incidence of Anogenital Warts in Young Men
Condition: Condylomata Acuminata
Interventions: Biological: (Gardasil) human papillomavirus (types 6, 11, 16, 18) recombinant vaccine;   Biological: Comparator: placebo (unspecified)
6 Not yet recruiting Human Papillomavirus (HPV) Genotypes in Genital Warts in Colombian Population
Conditions: Genital Warts;   HPV Infections
Intervention: Procedure: Biopsy Excisional
7 Active, not recruiting Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts
Condition: Genital Warts
Interventions: Drug: Imiquimod A;   Drug: Imiquimod B;   Drug: Placebo
8 Completed Study to Test the Safety of HPV Vaccine in Women
Conditions: Cervical Cancer;   Genital Warts
Interventions: Biological: V501, Gardasil, Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine / Duration of Treatment : 4 Years;   Biological: Comparator: placebo (concomitant-vaccine matched) / Duration of Treatment : 4 Years
9 Recruiting Alternate Dosing Schedules Study for HPV Vaccine
Conditions: Cervical Cancer;   Genital Warts
Intervention:
10 Completed Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)
Conditions: Cervical Cancer;   Genital Warts
Intervention: Biological: V501, Gardasil, human papillomavirus (types 6, 11, 16, 18) recombinant vaccine / Duration of Treatment: 4 years
11 Completed Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil)
Conditions: Cervical Cancer;   Genital Warts
Intervention: Biological: V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine / Duration of Treatment: 4 years
12 Completed A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine
Conditions: Cervical Cancer;   Genital Warts
Intervention: Biological: HPV (Human Papillomavirus) Vaccine
13 Completed Broad Spectrum HPV Vaccine Dose Ranging Study
Conditions: HPV;   Cervical Cancer;   Premalignancy Anogenital Warts
Interventions: Biological: Comparator: Gardasil;   Biological: Comparator: octavalent HPV Vaccine - dose formulation 1;   Biological: Comparator: octavalent HPV Vaccine - dose formulation 2;   Biological: Comparator: octavalent HPV Vaccine - dose formulation 3
14 Recruiting Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women
Conditions: Cervical Cancer;   Vulvar Cancer;   Vaginal Cancer;   Genital Warts;   Human Papillomavirus Infection
Interventions: Biological: Comparator: GARDASIL™;   Biological: Comparator: V503
15 Completed Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts
Condition: Genital Warts
Interventions: Drug: GS-9191 ointment;   Drug: GS-9191;   Drug: Placebo
16 Completed Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine
Conditions: Cervical Cancer;   Genital Warts
Intervention: Biological: V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine / Duration of Treatment: 4 years
17 Active, not recruiting A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL
Conditions: Cervical Cancer;   Vulvar Cancer;   Vaginal Cancer;   Genital Warts;   Human Papillomavirus Infection
Interventions: Biological: V504;   Biological: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine;   Biological: Placebo (unspecified)
18 Completed Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts
Condition: Genital Warts
Interventions: Drug: Imiquimod;   Other: vehicle cream
19 Recruiting Anogenital Wart Burden and Cost of Illnesses
Condition: Warts
Intervention:
20 Completed Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)
Conditions: Cervical Cancer;   Genital Warts
Intervention: Biological: V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine / Duration of Treatment: 7 months

Previous Page Studies Shown (1-20) Next Page (21-22)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services